During the last session, Evolent Health Inc (NYSE:EVH)’s traded shares were 2.35 million, with the beta value of the company hitting 0.82. At the end of the trading day, the stock’s price was $11.23, reflecting an intraday loss of -0.53% or -$0.06. The 52-week high for the EVH share is $33.63, that puts it down -199.47 from that peak though still a striking 37.13% gain since the share price plummeted to a 52-week low of $7.06. The company’s market capitalization is $1.32B, and the average intraday trading volume over the past 10 days was 3.23 million shares, and the average trade volume was 2.60 million shares over the past three months.
Evolent Health Inc (EVH) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.14. EVH has a Sell rating from 0 analyst(s) out of 5 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 5 recommend a Buy rating for it.
Evolent Health Inc (NYSE:EVH) trade information
Evolent Health Inc (EVH) registered a -0.53% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.53% in intraday trading to $11.23, hitting a weekly high. The stock’s 5-day price performance is -4.26%, and it has moved by 32.43% in 30 days. Based on these gigs, the overall price performance for the year is -0.18%. The short interest in Evolent Health Inc (NYSE:EVH) is 15.23 million shares and it means that shorts have 7.94 day(s) to cover.
The consensus price target of analysts on Wall Street is $17, which implies an increase of 33.94% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $14 and $20 respectively. As a result, EVH is trading at a discount of -78.09% off the target high and -24.67% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 25.98%. While earnings are projected to return -13.86% in 2025, the next five years will return 25.04% per annum.
EVH Dividends
Evolent Health Inc is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Evolent Health Inc (NYSE:EVH)’s Major holders
Evolent Health Inc insiders own 1.41% of total outstanding shares while institutional holders control 109.46%, with the float percentage being 111.03%. WELLINGTON MANAGEMENT GROUP LLP is the largest shareholder of the company, while 315.0 institutions own stock in it. As of 2024-06-30, the company held over 11.17 million shares (or 9.7383% of all shares), a total value of $213.55 million in shares.
The next largest institutional holding, with 11.06 million shares, is of VANGUARD GROUP INC’s that is approximately 9.64% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $211.39 million.
Also, the Mutual Funds coming in first place with the largest holdings of Evolent Health Inc (EVH) shares are VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund and MUTUAL FUND SERIES TRUST-Eventide Gilead Fund . Data provided on Apr 30, 2025 indicates that VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund owns about 6.78 shares. This amounts to just over 5.77 percent of the company’s overall shares, with a $76.12 million market value. The same data shows that the other fund manager holds slightly less at 4.26, or about 3.63% of the stock, which is worth about $47.89 million.
